Document is current
Any future updates will be listed below
-
Authors
Vingerder, Damien
Sejournet, Lucas
Allignet, Benoit https://orcid.org/0000-0001-7275-0773
Agard, Emilie
Mathis, Thibaud https://orcid.org/0000-0002-1418-1872
Fenniri, Inès
Matagrin, Benjamin
Denis, Philippe
Burillon, Carole
Kodjikian, Laurent
Dot, Corinne https://orcid.org/0000-0003-4398-3978
- License Information
-
More Information
Article History
Received: 15 December 2024
Revised: 11 June 2025
Accepted: 31 October 2025
First Online: 14 November 2025
Competing interests
: CD is a consultant for Abbvie, Bayer, Horus Pharma, Novartis and Roche. L. Kodjikian is a consultant for Allergan/Abbvie, Bayer, Horus, Novartis, Roche and Théa. T. Mathis is a consultant for Allergan/Abbvie, Bayer, GSK, Horus and Novartis. All other authors have no conflicts of interest to declare.
